Kanellopoulos Anastasios John
LaserVision gr Institute, Athens, Greece; New York University Medical School, New York City, NY, USA.
Clin Ophthalmol. 2012;6:645-52. doi: 10.2147/OPTH.S31250. Epub 2012 May 1.
This research comprised a laboratory evaluation of a novel refractive surgery technique involving sequential corneal subsurface shrinkage-driven reshaping using a continuous wave mid-infrared laser application followed by stiffening via rapid transepithelial higher fluence collagen cross-linking for shape persistence/longevity on cadaver corneas.
Ten cadaver corneas were used in this study. During use, all were affixed in an artificial chamber. Thermal delivery entailed a continuous wave laser at 2013 nm wavelength, approximately 650 mW power under scanner control (about 3 mm/sec linear draw speed), with a planoconcave sapphire applanation lens cooled to 8°C. Group 1 (n = 5, myopic treatment) eyes were exposed to three concentric annuli with diameters of 3 mm, 4 mm, and 5 mm. Group 2 (n = 5, hyperopic treatment) eyes were exposed to three concentric annuli with diameters of 6 mm, 7 mm, and 8 mm. The clinical change in shape of the cornea was visualized immediately under a slit-lamp. A transepithelial higher fluence corneal collagen cross-linking step followed each thermal treatment, comprising 0.1% riboflavin drops with 0.02% benzalkonium chloride and 0.2% carboxymethlycellulose in deuterated water (D(2)O) applied on the epithelium corneal surface for 10 minutes. Next, each cornea was exposed to 10 mW/cm(2) of ultraviolet A (365 nm) light for 10 minutes. The corneas were evaluated before and after thermal remodeling and cornea collagen cross-linking for corneal topography, corneal optical coherence tomography, cornea Scheimpflug tomography, and clinical photographs.
The histopathology effect was noted clinically as concentric white rings underneath the epithelium and Bowman's membrane, with the lesion depth extending down to 400 μm in the mid stroma of the cornea. This was confirmed by corneal anterior segment optical coherence tomography. The topographic change noted was a 4-8 diopter hyperopic shift in group 1 and a 2-6 diopter myopic shift in group 2.
This novel refractive surgery technique appears to generate a significant refractive change (+/-) in the cornea, without affecting the epithelium or Bowman's membrane and without any visible epithelial defect. The transepithelial collagen cross-linking used as a second step in the same procedure aims to stabilize this effect in the long term. Further clinical studies are planned to validate these initial clinical results.
本研究包括一项新型屈光手术技术的实验室评估,该技术涉及使用连续波中红外激光进行连续角膜基质层收缩驱动的重塑,随后通过快速经上皮高能量胶原蛋白交联进行强化,以在尸体角膜上保持形状持久/长期稳定。
本研究使用了10只尸体角膜。使用过程中,所有角膜均固定在人工腔室中。热传递采用波长为2013nm的连续波激光,在扫描仪控制下功率约为650mW(线性扫描速度约为3mm/秒),使用冷却至8°C的平凹蓝宝石压平透镜。第1组(n = 5,近视治疗)的眼睛暴露于直径为3mm、4mm和5mm的三个同心环带。第2组(n = 5,远视治疗)的眼睛暴露于直径为6mm、7mm和8mm的三个同心环带。角膜形状的临床变化在裂隙灯下立即可视化。每次热处理后进行经上皮高能量角膜胶原蛋白交联步骤,包括在角膜上皮表面滴加含0.02%苯扎氯铵和0.2%羧甲基纤维素的0.1%核黄素滴眼液,持续10分钟。接下来,每个角膜暴露于10mW/cm²的紫外线A(365nm)光下10分钟。在热重塑和角膜胶原蛋白交联前后,对角膜进行角膜地形图、角膜光学相干断层扫描、角膜Scheimpflug断层扫描和临床照片评估。
组织病理学效应在临床上表现为上皮和Bowman膜下方的同心白色环,病变深度延伸至角膜基质中层400μm。这通过角膜前段光学相干断层扫描得到证实。观察到的地形变化是,第1组有4 - 8屈光度的远视偏移,第2组有2 - 6屈光度的近视偏移。
这种新型屈光手术技术似乎能在角膜中产生显著的屈光变化(±),而不影响上皮或Bowman膜,且无任何可见的上皮缺损。在同一手术中作为第二步使用的经上皮胶原蛋白交联旨在长期稳定这种效果。计划进行进一步的临床研究以验证这些初步临床结果。